LCN2 expression has been shown to be up-regulated in ovarian, cervical tissue, and endometrial cancer, as well as human ovarian cancer cell lines [https://www.proteinatlas.org/, last accessed on 21.3.2024]. This evidence concerns the gene LCN2 and ovarian carcinoma.